Enhance human intelligence.
Two trajectories. One mission.
Drug therapies for the mind.
We design drug therapies for the hardest problems in the brain, from ADHD in childhood to cognitive decline in old age.
AI for the brain.
We build the models that find what others can't. Molecules that cross the blood-brain barrier, and the biology that decides whether they work.
BBB-Nuke.
The state-of-the-art AI platform for facilitating the design of drugs that reach the brain. Built in-house. 30% more accurate than CNS-MPO, the standard the field has relied on for a decade. Available to you now.
Score any molecule for blood-brain barrier penetration from a single SMILES string. Call it from your own code, or hand it to Claude.
What we're thinking about.
Temitope Sobodu, PhD
Temi is a pharmacologist focused on optimizing AI models for early drug discovery, and sets the strategic direction and roadmap for Attention Labs. He holds a PhD in pharmacology and brings prior business development experience from Pfizer and Sanofi, combining scientific depth with strategic leadership.
